###### Key messages

What is already known on this subject?
======================================

-   The gut microbiota is associated with colorectal cancer (CRC) development.

-   Faecal microbiota has potential as a biomarker for CRC.

-   Putatively oral bacteria are more abundant on CRC biopsies and *Fusobacterium nucleatum* has been reported to be enriched in IBD.

-   A 'Western diet' contributes to CRC development.

What are the new findings?
==========================

-   We developed an oral and faecal microbiota-based classifier that distinguished individuals with CRC and adenomas from healthy controls. The discriminatory power particularly for adenomas was higher than for currently used tests.

-   We detected similar networks of oral bacteria at both oral and colonic mucosal surfaces, including in individuals with colonic lesions (on and off the tumour), healthy controls and children with and without Crohn's disease.

-   A microbiota rich in Lachnospiraceae was negatively correlated with 'Western diet' and colonic colonisation with oral bacteria, including oral pathogens associated with CRC, suggesting a protective role, possibly mediated through habitual diet.

How might it impact on clinical practice in the foreseeable future?
===================================================================

-   If the suitability of oral microbiota screening for the detection of CRC and polyps can be verified in larger study groups, this could significantly improve current screening programmes.

Introduction {#s1}
============

Microbes have been implicated in the pathogenesis of several human cancers, most strikingly in the case of *Helicobacter pylori* and gastric carcinoma and some gastric lymphomas.[@R1] *H. pylori* is now designated a gastric carcinogen and a preclinical risk factor. Current non-invasive screening approaches for colon cancer such as faecal immune test (FIT) and faecal occult blood test (FOBT) have very low sensitivity for detecting early lesions, and more reliable biomarkers are required. We and others have reported changes in the faecal or colonic mucosal microbiota in patients with colorectal cancer (CRC),[@R3] and data from several animal models have implicated the microbiota in the pathogenesis of CRC.[@R9] Our finding of a microbiota configuration associated with benign colonic polyps that is intermediate between that of controls and those with cancer suggests that the microbiota might provide a potential biomarker predictive of the risk of later development of cancer. It also suggests that an intervention could theoretically be applicable years before the development of the disease. The additional finding by us and others of microbes that are normally associated with the oral cavity[@R3] being present in the faecal and mucosal microbiota linked with CRC prompted us to investigate the oral microbiota in colon cancer as a first step in determining if it might serve as a more accessible sampling site for convenient and widespread screening. Previously, several groups reported the applicability of faecal microbiota profiling as a tool for detection of CRCs,[@R4] particularly in conjunction with the FOBT[@R5] or FIT.[@R4] Moreover, distinct bacterial profiles in the oral cavity have been associated with oral cancers[@R15] and with esophageal[@R17] and pancreatic cancers.[@R18] A single study identified significant differences in the bacteria present in oral rinse samples from individuals with CRC compared with healthy controls.[@R20]

Here, we present the findings of an extended CRC study population and include an assessment of the oral microbiota. We developed a classifier using oral and faecal microbiota profiles with high specificity and sensitivity particularly for the detection of colorectal polyps. Furthermore, we found similar bacterial networks at both oral and colonic mucosal surfaces that were enriched in CRC and also detectable in healthy tissue. However, we could not find a direct link between oral and colonic microbiota such that elevated abundance of bacteria in the oral cavity was predictive of colonic colonisation by the same taxa. Rather, colonic presence and abundance of oral pathogens was negatively associated with the colonic abundance of Lachnospiraceae. We also detected weak negative correlations of Lachnospiraceae with dietary habits reminiscent of a 'Western diet'. Lastly, in a meta analysis, we found similar networks of oral bacteria to be enriched in colonic tissue of children in a recent Crohn's disease study. Thus, our data indicate that oral bacterial networks found in the colon already establish at an early age and before disease can be detected. Lachnospiraceae may protect against colonisation with oral bacteria, possibly mediated through dietary habits. Colonic oral bacterial overgrowth is not unique to CRC but associated with Crohn's disease.

Materials and methods {#s2}
=====================

Sampling, DNA extraction and 16S rRNA gene amplicon sequencing {#s2a}
--------------------------------------------------------------

Faecal samples were self-collected and sent to the laboratory within 1 hour of defecation. Tissue samples were either collected during colorectal surgery or colonoscopy. Oral samples were obtained by rubbing the inside of both cheeks with a swab. Exclusion criteria were a personal history of CRC, IBD and irritable bowel syndrome. A breakdown of the analysed samples is given in [table 1](#T1){ref-type="table"}. Detailed demographic information for each individual is given in (online [supplementary table 1](#SP8){ref-type="supplementary-material"}).
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###### 

Clinical data of the studied individuals

  Sample type       Samples (n)   Age (mean±SD)   BMI (mean±SD)   Males   Tumour size (mean±SD)   Rectal bleeding (%)   Alcohol (1st quantile, third quantile) (units/week)   Currently smoking (%)
  ----------------- ------------- --------------- --------------- ------- ----------------------- --------------------- ----------------------------------------------------- -----------------------
  Tissue controls   59            53.2±13.5       27.4±6.1        44.1    NA                      57.7                  1 (1, 10)                                             4
  Off CRC           74            66±11.3         28.7±5.7        66.7    3.2±1.8                 65.6                  2 (1, 10)                                             10.4
  Off Polyps        31            61.6±14.8       28.8±5          71      NA                      38.7                  1 (1, 10)                                             13.3
  On CRC            65            67±11.6         28.8±5.8        60.9    3.6±2                   64.4                  2 (0.8, 10)                                           5
  On Polyps         2             76.5±0.7        27.4±0.9        100     NA                      50                    7.5 (4.2, 10.8)                                       0
  Stool controls    62            63.9±11.1       28.2±5.4        50.9    NA                      55.6                  1 (0.2, 6.2)                                          0
  Stool CRC         69            65.3±10.8       28.4±6.1        66.7    3.1±1.7                 65.5                  2 (1, 11.2)                                           11.3
  Stool polyp       23            60.4±13.4       29.3±5.4        78.3    NA                      39.1                  4 (1, 13.5)                                           17.4
  Swab controls     25            51.5±12.4       27.1±5.5        37.5    NA                      57.9                  1 (1, 6)                                              0
  Swab CRC          45            65.7±10.9       27.1±5          56.1    3.3±1.9                 66.7                  2 (1, 9)                                              0
  Swab polyp        21            59.2±15.1       28.5±5.2        71.4    NA                      38.1                  1 (1, 10)                                             10

BMI, body mass index; CRC, colorectal cancer.

Genomic DNA was extracted using the AllPrep DNA/RNA kit from Qiagen (Hilden, Germany). 16S rRNA gene amplicon sequencing libraries of the V3-V4 region were prepared, and pools of amplicons were sequenced at GATC (Konstanz, Germany) on a MiSeq sequencing instrument (Illumina, San Diego, California, USA) using 2×250 bp chemistry.

16S amplicon sequences from our Irish cohort were processed as previously described.[@R3] We also conducted a meta-analysis with amplicon sequencing data pertaining to Gevers *et al*[@R21] and processed data associated with this study similarly. In order to compare bacterial operational taxonomic units (OTUs) obtained in the Irish CRC cohort (sequenced region: V3-V4) with OTUs obtained in the Crohn's disease cohort (V4), we shortened the sequences of the CRC cohort to the sequenced region of the CD cohort using cutadapt,[@R22] and then processed the sequences of the two studies together.

Statistical analysis was carried out in R.[@R23]

A more detailed description of the employed protocols is available as (online [supplementary information](#SP11){ref-type="supplementary-material"}).
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CRC classifier {#s2b}
--------------

The Random forest (RF) classifier to determine OTUs suitable as biomarkers of colonic lesions was described elsewhere.[@R4] In brief, we used log-ratio transformed values of OTUs present in at least 5% of individuals as input to the function AUCRF of the AUCRF package.[@R24] Significance of difference between ROC curves was assessed using the function roc.test of the pROC package.[@R25] A schematic is depicted in online [supplementary figure 1](#SP1){ref-type="supplementary-material"}. We also employed an in-house pipeline for classification that consisted of a two-step procedure: the least absolute shrinkage and selection operator (LASSO) feature selection, followed by RF modelling. The full dataset was preprocessed (ie, filtered to exclude features that were present in less than 5% of individuals). Ten-fold cross-validation (CV) was applied to the data. Within each iteration of the 10-fold CV, feature selection was performed using the LASSO algorithm on 90% of the dataset, which was used as a training set to generate a predictive model within each iteration. LASSO improves accuracy and interpretability of models by efficiently selecting the relevant features, a process which is tuned by the parameter lambda. The model was generated within the 10-fold CV training data by filtering the dataset to include only the features selected by the LASSO algorithm, and RF was used for subsequent modelling of this subset. Both LASSO feature selection and RF modelling were performed within the 10-fold CV, which generates an internally validated list of features and an internal 10-fold prediction in order to generate an estimate of the predictive value of the overall model. We report both the results from the default threshold selected by the model and an Youden optimised result where the threshold has been optimised to improve the sensitivity and specificity. A schematic for this protocol is presented in online [supplementary figure 2](#SP2){ref-type="supplementary-material"}).
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Results {#s3}
=======

The oral microbiota is significantly different in CRC {#s3a}
-----------------------------------------------------

We analysed the microbiota from individuals with CRC, colorectal polyps and healthy controls from multiple body sites ([table 1](#T1){ref-type="table"}) using 16S rRNA gene amplicon sequencing. The 10 most abundant bacterial genera across all oral swab samples were *Streptococcus* (30.7% of all assigned reads), *Haemophilus* (14.2%), *Neisseria* (8.8%), *Prevotella* (6.6%), *Fusobacterium* (5.4%), *Veillonella* (5.4%), *Leptotrichia* (3.9%), *Rothia* (3.9%), *Actinomyces* (2.9%) and *Porphyromonas* (2.4%) (online [supplementary table 2](#SP9){ref-type="supplementary-material"}). These proportional abundance values are similar to those reported in previous studies of the microbiota associated with the oral cavity.[@R26]
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Microbiota profiling by sequencing identifies bacterial taxa as sequence-based divisions or OTUs. The overall oral profile of bacterial OTUs (grouped at 97% sequence similarity) was significantly different between individuals with CRC and healthy controls (permutational analysis of variance of the unweighted UniFrac distance, [figure 1](#F1){ref-type="fig"}). Moreover, eight oral microbiota OTUs were differentially abundant between individuals with CRC and healthy controls (ANCOM, FDR\<0.05). Differentially abundant OTUs were classified as *Haemophilus*, *Parvimonas*, *Prevotella*, *Alloprevotella*, *Lachnoanaerobaculum*, *Neisseria* and *Streptococcus* (online [supplementary table 2](#SP9){ref-type="supplementary-material"}). Almost all differentially abundant OTUs (7/8) were less abundant in individuals with CRC than in healthy individuals. Even though the overall microbiota was similar between individuals with polyps and healthy controls, four individual bacterial OTUs were differentially abundant between the two groups (online [supplementary table 2](#SP9){ref-type="supplementary-material"}), three of which were also differentially abundant in CRC.

![The oral microbiota of individuals with CRC is statistically significantly different from that of healthy individuals. Shown is the PCoA of the unweighted UniFrac distance (significance assessed using PERMANOVA as described in Materials and Methods). CRC, colorectal cancer; PERMANOVA, permutational analysis of variance.](gutjnl-2017-314814f01){#F1}

Oral and stool microbiota as biomarkers of CRC {#s3b}
----------------------------------------------

Current non-invasive screening tools for CRC can reliably detect advanced carcinomas based on traces of blood in faeces released by colonic lesions, but these methods suffer from low sensitivity for detecting early lesions.[@R28] Motivated by the findings presented above, we assessed the suitability of oral microbiota as a screening tool for identifying subjects with polyps and CRC by employing a previously established RF classification methodology[@R4] (online [supplementary figure 1](#SP1){ref-type="supplementary-material"}). The model identified 16 oral microbiota OTUs that distinguish individuals with CRC from healthy controls. The sensitivity of detection was 53% (95% CI (31.11% to 93.33%) with a specificity of 96% (area under the curve (AUC): 0.9; 95% CI (0.83 to 0.9); [figure 2](#F2){ref-type="fig"} and online [supplementary figure 3](#SP3){ref-type="supplementary-material"}). The model could also be used to detect individuals with colorectal polyps based on the abundance of 12 oral OTUs (sensitivity 67%; 95% CI (23.81% to 90.48%); AUC: 0.89; 95% CI (0.8 to 0.89); [figure 2](#F2){ref-type="fig"} and online [supplementary figure 4](#SP4){ref-type="supplementary-material"}). Our findings are also consistent with previous reports[@R4] in that faecal microbiota abundance of selected OTUs is able to distinguish individuals with CRC or polyps from healthy persons ([figure 2](#F2){ref-type="fig"}). However, the sensitivity of our model to use faecal microbiota to detect individuals with CRCs was considerably lower (sensitivity 22%; 95% CI (4.35% to 52.17%); specificity 95%, AUC 0.81; 95% CI (0.73 to 0.81)) than previously reported. A combination of oral and stool microbiota data improved the model sensitivity to 76% (95% CI (59.9% to 92%), AUC: 0.94; 95% CI (0.87 to 0.94) for the detection of CRCs and 88% for polyps (95% CI (68.75% to 100%), AUC: 0.98; 95% CI (0.95 to 0.98) for the detection of polyps (both: specificity 94% or more) ([figure 2](#F2){ref-type="fig"}). Analysis of the abundances of 28 bacterial OTUs were optimal for the differentiation between individuals with polyps and healthy controls (for 12 OTUs, the abundance in the oral cavity was used, while for 16 OTUs, the faecal abundance was used); the model for the detection of CRCs used 63 OTUs (29 oral OTUs and 34 stool OTUs).
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![Oral and stool microbiota profiles are potential tools for the detection of CRC. (A and B) Receiver operating characteristic curves (ROC) and area under the curve (AUC) values for the prediction of CRC (A) and polyps (B) using microbiota profiles from oral swabs, stool or a combination of both. AUC values were highest for the combination test. Significance determined after DeLong (Materials and Methods). Sample numbers: swabs: n=25 (healthy controls), n=45 (CRCs), n=21 (polyps); stool: n=62 (healthy controls), n=69 (CRCs), n=23 (polyps); and combination: n=19 (healthy controls), n=25 (CRCs), n=16 (polyps). CRC, colorectal cancer; FPR, false-positive rate; TPR, true-positive rate.](gutjnl-2017-314814f02){#F2}

We were able to confirm the predictive value of the oral microbiota for CRC screening by employing an in-house pipeline using a LASSO feature selection step and a RF classifier within a 10-fold CV pipeline (see online [supplementary figure 2](#SP2){ref-type="supplementary-material"}). This methodology, using the default probability threshold and when applied to the oral swab microbiota dataset, yielded 74% sensitivity and 90% specificity (AUC 0.91) for the prediction of adenomas and 98% sensitivity and 70% specificity (AUC 0.96) for the prediction of CRC, respectively. For a full list of values, please see online [supplementary table 3](#SP10){ref-type="supplementary-material"}.
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Oral bacteria are abundant in the gut microbiota of individuals with CRCs and polyps and form similar coabundance networks on both oral mucosa and colonic tissue {#s3c}
-----------------------------------------------------------------------------------------------------------------------------------------------------------------

We extended our analysis of oral bacterial networks to the gut because we and others have reported the over-abundance of putatively oral bacteria on CRCs and polyps.[@R3] These bacteria have also been linked to an inflammatory host response and accelerated progression of CRC.[@R3]

Our analysis focused on the 17 OTUs that were shared between the oral cavity and CRC and polyp samples; that is, OTUs that were detected in 37% of both tissue samples and oral swabs. As with our previous approach to microbiota analysis from cancerous and healthy colon tissue,[@R3] we clustered these bacteria based on their abundance profiles in tumour samples ([figure 3A](#F3){ref-type="fig"}). The two tumour-associated bacterial coabundance groups (CAGs) thus identified comprised (a) oral pathogens previously linked with late colonisation of oral biofilms and with human diseases including CRC (eg, *F. nucleatum*, *Parvimonas micra*, *Peptostreptococcus stomatis*, *Dialister pneumosintes* and others[@R30]), designated here as the oral pathogen CAG and comprising seven OTUs in total. The second CAG comprised dominant bacteria in early dental biofilm formation, including *Actinomyces*, *Haemophilus*, *Rothia*, *Streptococcus* and *Veilonella* spp.,[@R34] genera also associated with relatively healthy tooth pockets[@R32] (so-called biofilm CAG; 10 OTUs). Collectively, the read counts of OTUs found in the pathogen CAG and the biofilm CAG comprised more than 55% of the average number of sequence reads from oral mucosal surfaces. Bacteria of these two CAGs were significantly more abundant both on and off the tumour compared with healthy controls ([figure 3B](#F3){ref-type="fig"}).

![Oral bacterial networks are detected in colonic mucosa and are enriched in CRC. (A) Clustering of the 17 oral bacterial OTUs associated with tumour tissue into two coabundance groups (CAGs). CAGs were defined on the basis of the clusters in the vertical or horizontal trees and named after their most notable characteristic. Column and row bars indicate bacterial CAGs (as per legend to the bottom right) and fold change between individuals with CRC and healthy controls (as per legend to the bottom left). Legend top left: colour-scale correlation coefficient. (B) The two CAGs comprising typically oral bacteria (oral pathogen CAG and biofilm CAG) were more abundant in colonic microbiota of CRC. Shown are boxplots of relative abundances of the two CAGs in colon tissue. n (controls)=59, n (off)=105, n (tumours)=67. CRC, colorectal cancer; FDR, false discovery rate; HC, healthy controls; OTUs, operational taxonomic units.](gutjnl-2017-314814f03){#F3}

Additionally, we analysed oral bacterial networks detected across different disease stages and different sample types, that is, in (1) oral swabs, (2) in undiseased tissue from individuals with CRC and polyps, (3) in tissue from healthy controls, (4) in stool from individuals with CRC and (5) in stool from healthy controls. Strikingly, the bacterial networks detected on CRC biopsies ([figure 3A](#F3){ref-type="fig"} and [figure 4A](#F4){ref-type="fig"}) were similar in oral swabs ([figure 4B](#F4){ref-type="fig"}), undiseased tissue samples from individuals with CRC and colonic polyps ([figure 4C](#F4){ref-type="fig"}). Moreover, similar networks of bacterial OTUs from the oral cavity were also found in tissue samples from healthy individuals ([figure 4D](#F4){ref-type="fig"}), indicating that these networks exist prior to the development of CRC and could theoretically be involved in the initiation of CRC. These networks were only partially detectable in faecal samples from individuals with CRC or polyps ([figure 4E](#F4){ref-type="fig"}) and faecal microbiota of healthy controls ([figure 4F](#F4){ref-type="fig"}), suggesting tight association with the mucosa and highlighting the limitations of faecal samples for CRC microbiota detection. Details of the overlap of OTUs between the different sample types are presented in the Venn diagram in online [supplementary figure 5](#SP5){ref-type="supplementary-material"}.
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![Bacterial networks detected at colonic mucosal surfaces (panels A,C,D) are similar to those networks detected at oral mucosal surfaces (B) and were not or only partially detected in faecal samples (panels E,F). Shown are network plots of bacterial OTUs found in both the oral cavity and colonic microbiota in different groups of samples: (A) diseased colorectal tissue (ON; 65 individuals with CRC and 2 polyps), (B) oral swab samples (45 individuals with CRC, 21 individuals with polyps and 25 healthy controls), (C) undiseased colorectal tissue (off) from 74 individuals with CRC and 31 individuals with polyps, (D) colorectal tissue from 59 healthy controls, (E) faecal samples from 69 individuals with CRC and 23 individuals with polyps and (F) faecal samples from 62 healthy controls. For each group of samples, the OTUs shared with the oral cavity was determined separately. The size of each node (OTU) correlates to the mean abundance of each OTU across all samples in each respective sample group. The colour of each node corresponds to the CAG determined using diseased colorectal tissue only ([figure 3A](#F3){ref-type="fig"}). One OTU (no. 7, panel C) was only shared between undiseased colorectal tissue and the oral cavity, and it is thus coloured grey. The width of each edge corresponds to the p value of the correlation between each respective node (lower p value, higher line width). The location of each node was determined by a PCoA of the correlation distance as described in Materials and Methods. Only nodes with at least one significant edge are shown. Legend to the right: genus-level classification using RDP reference, version 14 of OTU representative sequences. CRC, colorectal cancer; ON, sample from the cancer or polyp; OTUs, operational taxonomic units; PCoA, Principal Coordinates Analysis; RDP, Ribosomal Database Project.](gutjnl-2017-314814f04){#F4}

Low colonic abundance of Lachnospiraceae favours colonisation of gut mucosa by oral pathogens linked to CRC {#s3d}
-----------------------------------------------------------------------------------------------------------

Given the associations of oral bacteria with the altered microbiota found on CRC biopsies and our current finding that characterising oral microbiota profiles has potential for CRC detection, we hypothesised that the oral microbiota might generally be reflected in gut microbiota composition. However, bacteria typically enriched on colorectal tumours and found in both the oral cavity and the colon, such as *Porphyromonas*, *Parvimonas* and *Fusobacterium*, were less abundant in the oral mucosa of individuals with CRC compared with healthy controls (online [supplementary table 2](#SP9){ref-type="supplementary-material"}, statistically significant difference for one *Parvimonas* OTU). Furthermore, the total number of bacteria of the oral pathogen CAG ([figure 3](#F3){ref-type="fig"}) detected in the oral cavity was lower in CRC (p\<0.01; Wilcoxon rank-sum test). Surprisingly, we even detected statistically significant negative correlations between oral and colonic abundance of OTUs of the oral pathogen CAG ([figure 3](#F3){ref-type="fig"}) classified as *Dialister* (Kendall's $\tau$=−0.34, p\<0.05, n=65 sample pairs), *Peptostreptococcus* ($\tau$=−0.28, p\<0.05) and *Parvimonas* ($\tau$=−0.24, p\<0.05).

We then asked whether the overall gut microbiota composition of a subject, irrespective of having cancer or being a healthy control, determines whether oral bacteria become part of the gut microbiota. To test this, we first determined bacterial CAGs in this extended dataset for all OTUs (as opposed to the analysis shown in [figure 3A](#F3){ref-type="fig"}, which only considers the 17 OTUs shared between the oral cavity and tumours) at colonic lesions ([figure 5A](#F5){ref-type="fig"}) and in colonic mucosa of healthy individuals (CAG plot not shown). Similar to our previous analyses,[@R3] OTUs with increased relative abundance in CRC were predominantly clustered into Bacteroidetes, *Prevotella* and oral bacterial CAGs, whereas OTUs in the Lachnospiraceae CAG were mostly less abundant in individuals with CRC ([figure 5A](#F5){ref-type="fig"}). Detailed analysis of the correlations between the abundance of bacteria shared between the oral cavity and colonic tissue ([figure 3](#F3){ref-type="fig"}) and the abundance of other colonic mucosa-associated bacteria revealed that oral pathogen CAG OTUs were strongly negatively correlated with Lachnospiraceae CAG OTUs ([figure 5A](#F5){ref-type="fig"}, dark green-coloured CAG). More specifically, 125 of the 130 (96%) negative correlations (SparCC pseudo-p\<0.01) these oral bacterial OTUs had with other bacteria were with OTUs of the Lachnospiraceae CAG. We next analysed the prevalence of oral bacteria on colorectal tumours and found that most bacteria of the oral pathogen and biofilm CAGs, while often statistically significantly more abundant in CRC ([figure 4](#F4){ref-type="fig"}), only colonised \~40%--70% of cancers ([figure 5B](#F5){ref-type="fig"}), a phenomenon also noted by others.[@R29] When we compared the colonic abundance of the other bacterial CAGs detected at colorectal lesions ([figure 5A](#F5){ref-type="fig"}) between these two groups, prevalence of bacteria of the oral pathogen CAG was associated with decreased abundance of the Lachnospiraceae CAG in both healthy individuals (p\<0.1, Wilcoxon rank-sum test) and individuals with colonic lesions (p\<0.01). Lastly, we detected a negative association between the abundance of the Lachnospiraceae CAG and and a 'Western diet', even though the signal was weak (see online [supplementary information](#SP11){ref-type="supplementary-material"} for details). In summary, our data suggest that colonic establishment of a putatively pathogenic oral-like community is more common in individuals with CRC and colonic polyps and in individuals with a low colonic abundance of Lachnospiraceae, a family of butyrate-producing Clostridia already associated with reduced risk of colon cancer. Colonisation of the gut by oral bacteria associated with CRC may be partially mediated or facilitated by consuming a diet high in fat and carbohydrates (typical 'Western Diet').

![Oral bacterial colonisation of human CRCs is negatively associated with the colonic mucosal abundance of the Lachnospiraceae CAG. (A) The relative abundance of oral pathogens at colonic lesions (found mostly in bright red CAG) is negatively correlated with the relative abundance of OTUs clustered in a CAG mainly comprising Lachnospiraceae (Lachnospiraceae CAG; dark green CAG). Shown is the heatplot of the correlation values between OTUs detected at colonic mucosal surfaces. CAGs were defined on the basis of the clusters in the vertical or horizontal trees and named after their most notable characteristic. Column and row bars indicate bacterial CAGs (as per legend to the bottom right), fold change between individuals with CRC and healthy controls (as per legend to the bottom left) and bacterial CAGs determined with only the subset of 17 OTUs found both at colonic and oral mucosal surfaces ([figure 3A](#F3){ref-type="fig"}). Legend top left: colour-scale correlation coefficient. (B) Scatterplot of the colonic prevalence of bacterial OTUs associated with oral pathogen and biofilm CAGs ([figure 3A](#F3){ref-type="fig"}). Most OTUs were only detected on a subset of CRCs and polyps (circle) or healthy controls (triangle). CAGs, coabundance groups; CRCs, colorectal cancer; OTUs, operational taxonomic units.](gutjnl-2017-314814f05){#F5}

Orally derived bacteria and non-neoplastic colonic disease {#s3e}
----------------------------------------------------------

To determine if colonic colonisation with orally derived bacteria occurs only in older people and if it occurs in other disorders, we included 16S rRNA sequences from a large microbiota dataset of \>300 children with and without CD[@R21] into our analysis. To facilitate comparison of the two datasets, we reanalysed our sequences from the oral cavity and tumour mucosa using only the shared sequence fragment (16S rRNA variable region 4) together with the CD data. We detected similar relationships of bacteria in both CD and CRC, particularly with regards to the Lachnospiraceae, Bacteroidetes and Pathogen CAGs ([figure 6](#F6){ref-type="fig"} and for comparison [figure 5](#F5){ref-type="fig"} and online [supplementary figures 3 and 4](#SP3 SP4){ref-type="supplementary-material"}). However, we could not detect a *Prevotella CAG* in children, which may reflect age and/or workflow-associated specifics. Strikingly, as in CRC, the pathogen CAG-type microbiota in children with CD comprised most of the statistically significantly more abundant bacterial OTUs, including OTUs also found in the oral cavity ([figure 6A](#F6){ref-type="fig"}, online[supplementary figures 6 and 7](#SP6 SP7){ref-type="supplementary-material"}). Detailed comparison of the OTUs found in the oral cavity and at colonic mucosal surfaces of individuals with CRC or CD revealed that the same OTUs classified as *Fusobacterium*, *Haemophilus*, *Streptococcus*, *Gemella*, *Rothia*, *Actinomyces*, *Granulicatella* and *Veilonella* were detected in both CD and CRC, whereas OTUs classified as *Peptostreptococcus* and *Parvimonas* were only found in CRC (see also [figure 6B](#F6){ref-type="fig"}). Some genera found in both CD and CRC contained OTUs that were unique to either CD or CRC (eg, the genus *Dialister* was found in both CD and CRC, but the OTUs were different). The same oral OTUs were detected in the two diseases, and the OTUs were organised in similar networks ([figure 6](#F6){ref-type="fig"}, panels C--E). Lastly, similar to CRC, the abundance of oral bacterial OTUs was negatively correlated with the abundance of Lachnospiraceae CAG OTUs in CD (91% of all negative correlations were with OTUs of the Lachnospiraceae CAG).

![Similarity of non-neoplastic and neoplastic colonic disease associated bacterial profiles. (A) Shown is the heatplot of the correlation values between OTUs associated with rectal tissue of children with and without CD.[@R21] CAGs were defined on the basis of the clusters in the vertical or horizontal trees and named after their most notable characteristic. Column and row bars indicate bacterial CAGs (as per legend to the bottom right), fold change between individuals with CD and healthy controls (as per legend to the bottom left). Additionally, two row and column bars indicate the CAG in the Irish CRC cohort ([figure 4A](#F4){ref-type="fig"}) and the fold change between individuals with CRCs/polyps and healthy controls. Legend top left: colour scale correlation coefficient. (B) Venn diagram of bacteria found in colorectal tissue of children with CD, colorectal tumours and oral swabs. (C--E) Network plots of bacterial OTUs found in both the oral cavity and different colonic tissue samples: (C) tumours (ON; 65 individuals with CRC and 2 polyps), (D) mucosa from children with CD (n=201) and (E) mucosa from healthy children (n=122). For each group of samples, the OTUs shared with the oral cavity was determined separately. The size of each node (OTU) correlates to the mean abundance of each OTU across all samples in each respective sample group. The width of each edge corresponds to the p value of the correlation between each respective node (lower p value, higher line width). The location of each node was determined by a PCoA of the correlation distance as described in Materials and Methods. Only nodes with at least one significant edge are shown. Legend to the right: genus-level classification using RDP reference, version 14 of OTU representative sequences. CAGs, coabundance groups; CD, Crohn's disease; CRCs, colorectal cancer; OTUs, operational taxonomic units; PCoA, Principal Coordinates Analysis; RDP, Ribosomal Database Project.](gutjnl-2017-314814f06){#F6}

Discussion {#s4}
==========

We present for the first time the combined analysis of the microbiota of subjects with CRC using samples from the oral cavity, colonic mucosal tissue and faeces. We show that profiling the bacteria associated with the oral cavity may have value in the detection of CRC. Our data also indicate that many bacterial taxa found in the oral cavity colonise a subset of colorectal tumours and form bacterial coabundance networks similar to those found in the oral cavity. These networks seem to form tight associations with the mucosa, because they are less readily detectable in faecal samples. Many of these bacterial taxa have previously been associated with oral biofilms. Together, these data suggest that oral-like biofilms also form on the mucosa of the colon. These bacteria were typically significantly more abundant on and off colorectal tumours as well as on and off colorectal polyps compared with the mucosa of healthy individuals and have been found to be associated with distinct mucosal gene expression profiles[@R3] suggesting a role in the development or progression of CRC. The mucosal abundance of Lachnospiraceae CAG microbiota was significantly lower in individuals with CRC and was inversely associated with the presence (and abundance) of CRC-associated, oral-like bacterial OTUs, in both healthy individuals and individuals with CRC and colorectal polyps. Thus, we postulate that Lachnospiraceae CAG-type microbiotas prevent colonic colonisation with CRC-associated, oral-like bacterial biofilms.

The use of microbiome structure as a biomarker of health and disease is gaining momentum particularly with the development of affordable high-throughput DNA sequencing technology. It is now possible to obtain deep knowledge about the microbiota of a sample for less than \$10 sequencing cost. Moreover, improved pipelines for in silico analysis of sequencing data enable researchers and clinicians to rapidly turn 16S rRNA amplicon sequencing data into clinically informative data without the need for dedicated large-scale computational facilities. Recent reports have shown the potential suitability of faecal microbiota profiles for screening for colonic lesions using 16S rRNA amplicon sequencing,[@R4] metagenomic sequencing[@R5] and qPCR.[@R14] In addition, diagnostic tests may be improved with a combination of microbiota information and the FIT.[@R4] The AUC values we obtained when using a combination of oral and faecal microbiota OTUs for CRC and adenoma detection (0.94 and 0.98, respectively) and the specificity (95% for both) and sensitivity (76% and 88%, respectively) were comparable or higher than those reported in the above-named studies (ranging from 0.64 to 0.93), suggesting that the inclusion of oral microbiota information has the potential to enhance the performance of current diagnostic tests. Particularly promising is the high sensitivity for the detection of adenomas (88%) because of the prognostic and therapeutic importance of early discovery of colonic disease. By comparison, Baxter *et al*[@R4] reported sensitivities below 20% for the detection of adenomas using either FIT or faecal microbiota composition alone and a sensitivity of below 40% when using a combination (specificity \>90%). Our analysis significantly improves on this, and we were able to confirm the value of the oral microbiota to predict colonic lesions with an independent classification strategy employing both LASSO and RF feature selection. We concede, however, that larger prospective studies that account for potential confounders such as age, tumour stage, smoking and alcohol consumption and that combine FIT, faecal microbiota and oral microbiota composition are needed to verify these promising results.

Numerous reports have noted the enrichment of oral-type bacteria on colorectal tumours or in faeces of individuals with CRC or adenomas, particularly *Fusobacterium*, *Peptostreptococcus*, *Porphyromonas* and *Parvimonas*,[@R3] and the association of these bacteria with microscopic inflammation of the colonic mucosa.[@R3] However, none of these studies included samples from the oral cavity, and direct comparisons were not possible. Dejea *et al* reported the association of bacterial biofilms with proximal CRCs[@R38] but identified no single genus that was consistently associated with tumour biofilms, not even genus *Fusobacterium*, nor did they report differences in overall microbiota composition of biofilm-positive tumours compared with biofilm-negative tumours. Interestingly, members of the tumour-associated biofilm CAG that we report here ([figure 3A](#F3){ref-type="fig"}) were indeed more prevalent and trended towards greater abundance in the mucosa of proximal tumours. This sidedness was not detected in healthy individuals indicating that biological specificities of proximal cancers may be responsible.

Previous research indicated a secondary role of *F. nucleatum*, one of the oral bacterial OTUs also found in this study, in the development of CRC. *F. nucleatum* had no effect on the proliferation on healthy colon epithelial cells[@R11] and was reported to be enriched on colorectal lesions compared with paired healthy tissue of individuals with CRC,[@R7] likely mediated by the overexpression of Gal-GalNAc.[@R39] These findings suggest a secondary involvement of *F. nucleatum* in the pathology of CRC. We also detected increased abundance of oral bacteria, including *F. nucleatum* at the site of the tumour, both compared with paired healthy tissue and healthy controls. However, the fact that we detect similar oral bacterial networks both off the tumour and in colonic mucosa of healthy controls makes it at least conceptually possible that such bacteria are indeed involved in the initiation of CRC and are both drivers and passengers of disease[@R40] mediated by thus far undiscovered mechanisms. Recently, Abed *et al*[@R39] showed that *F. nucleatum* enrichment is mediated through Fap2 binding to Gal-GalNAc expressed on CRCs and suggested a hematogenous route for translocation of the bacterium from the oral cavity. In addition to *F. nucleatum* enrichment in individuals with CRCs or polyps, we also detected enrichment of the same bacterial OTU in paediatric CD. It has been shown that a subset of CD and ulcerative colitis subjects (9/20) express Gal-GalNAc.[@R41] It is thus tempting to speculate that a similar mechanism also leads to *F. nucleatum* enrichment in CD. However, although Gal-GalNAc was shown in one previous study to be expressed on 21 out of 25 of adenocarcinomas,[@R41] we and others[@R11] detected *F. nucleatum* in 50% or less of CRCs, and high abundance is found in only \~10% of CRCs.[@R35] Thus, other mechanisms apparently modulate the abundance of *F. nucleatum* at the site of CRC. The enrichment of similar oral bacterial networks in both CRC and CD ([figure 6](#F6){ref-type="fig"}) may reflect general microbial community adaptation to a variable host response and it may be secondary in nature.

Our finding that the presence and abundance of oral pathogens both in CRC and in healthy individuals is negatively associated with the abundance of Lachnospiraceae such as *Anaerostipes*, *Blautia* and *Roseburia* suggests that these bacteria also play an important protective role. The concept that the gut microbiota protects against the colonisation of the bowel with environmental bacteria, including pathogens, is well established[@R42] and, according to our data, is also relevant in the context of CRC and CD. Moreover, the association we report here between the abundance of Lachnospiraceae and a healthy diet points to a new thread in the recognised diet--microbiota--disease paradigm, specifically in the concept of CRC, and provides further rationale for promoting a healthy diet to limit lifelong risk of this disease.
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